Back to Search Start Over

I have decided about my COVID-19 vaccine, what about my child?

Authors :
Shlomit Hon Snir
Sharon Teitler Regev
Source :
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Publication Year :
2022
Publisher :
Taylor & Francis Group, 2022.

Abstract

Vaccination has been instrumental in controlling the COVID-19 pandemic, with numbers of new cases decreasing rapidly even as restrictions to control the spread of the virus were removed. The first stage of the vaccination campaign in Israel covered individuals aged 16 and older, following the U.S. Food and Drug Administration’s approval of the vaccine. While the campaign was later extended to those aged 12 and older, some parents continue to have doubts and concerns about the vaccine. Data were collected via an online questionnaire during April 2021; 516 parents participated. This research adopted a holistic approach that combines factors relating to vaccine acceptance previously reported in the literature. The acceptance of pediatric COVID-19 vaccination among parents varied by their children’s age groups, at 44.7%, 53.2%, and 66.4% among parents with children aged 0–6, 6–12, and 12–16, respectively. The results of this study indicate that different sets of variables affect the willingness of parents to vaccinate their children, depending on their child’s age. Moreover, a holistic approach is necessary in order to correctly verify the significant variables. Parents who evaluate the vaccine as more beneficial have a higher probability of being willing to vaccinate. In addition, for ages 12–16, parental willingness to vaccinate is associated with access to information, trust, and neighborhood norms. Those evaluating information about the vaccine as more fake news show higher probability to vaccinate their children. The timing of the survey is highly relevant, especially considering the uncertainty about the effectiveness and side effects of the vaccine.

Details

Language :
English
ISSN :
21645515 and 2164554X
Volume :
18
Issue :
6
Database :
Directory of Open Access Journals
Journal :
Human Vaccines & Immunotherapeutics
Publication Type :
Academic Journal
Accession number :
edsdoj.4e041a34aa24370bd443c91973be9c6
Document Type :
article
Full Text :
https://doi.org/10.1080/21645515.2022.2129929